Jump to content

User:MDElliottMD/Sandbox/UGT1A1: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 May 2026

  • curprev 22:3922:39, 19 May 2026 MDElliottMD talk contribs 66 bytes −19,919 Redirect to canonical enzyme sandbox location. This User: page was a cross-session sandbox-location duplication artifact; the canonical enzyme sandbox pages live under Pharmacopedia:Pharmacogenomics sandbox/Enzyme <NAME>. Content (full retrofitted version) is preserved at the canonical title. Tag: New redirect
  • curprev 21:0921:09, 19 May 2026 MDElliottMD talk contribs 19,985 bytes +19,985 Sandbox-save UGT1A1 enzyme entity page (5th of 10 pharmacogenomics enzyme pages). History-first spine: Gilbert 1901 Paris + Bosma 1995 NEJM Amsterdam closure (UGT1A1*28 promoter TA-repeat discovery). Two CPIC/DPWG guidelines cited: Gammal 2016 CPIC atazanavir PMID 26417955, Hulshof 2023 DPWG irinotecan PMID 36443464. Plus mechanistic refs Iyer 1998 JCI PMID 9466980 (UGT1A1 + SN-38), Innocenti 2004 JCO PMID 15007088 (irinotecan + UGT1A1*28 + neutropenia). Plus Tukey & Strassburg 2000 Annu Rev...
Retrieved from "https://pharmacopedia.wiki/p/User:MDElliottMD/Sandbox/UGT1A1"